Literature DB >> 31822801

Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.

Ivonne A Montes-Mojarro1, Bo-Jung Chen1,2, Ana F Ramirez-Ibarguen3, Carmen M Quezada-Fiallos4, Wendy B Pérez-Báez4, Daniela Dueñas5, Sandro Casavilca-Zambrano5, Marcela Ortiz-Mayor6, Erica Rojas-Bilbao7, Hernan García-Rivello8, Maria F Metrebian9, Marina Narbaitz9, Carlos Barrionuevo5, Carmen Lome-Maldonado4, Irina Bonzheim1, Falko Fend1, Julia Steinhilber1, Leticia Quintanilla-Martinez10.   

Abstract

Extranodal NK/T-cell lymphoma (ENKTL) is an Epstein-Barr virus (EBV) associated lymphoma, prevalent in Asia and Latin America. Studies in Asian cohorts have identified some recurrent gene mutations in ENKTL; however, the mutational landscape of ENKTL in Latin America is unknown. In this study, we investigated the mutational profile and EBV strains of 71 ENKTL cases from Latin America (42 from Mexico, 17 from Peru, and 12 from Argentina) and compared it with Asian cohorts. The mutational analysis was performed by next generation sequencing (NGS) using an Ion AmpliSeq™ custom panel covering for the most frequently mutated genes identified in ENKTL. STAT3 was the most frequent mutated gene (16 cases: 23%), followed by MSN (10 cases; 14%), BCOR (9 cases; 13%), DDX3X (6 cases; 8%), TP53 (6 cases; 8%), MGA (3 cases; 4%), JAK3 (2 cases; 3%), and STAT5B (1 case; 1%). Mutations in STAT3, BCOR, and DDX3X were nearly mutually exclusive, suggesting different molecular pathways involved in the pathogenesis of ENKTL; whereas mutations in MGA, MSN, and TP53 were concomitant with other mutations. Most cases (75%) carried Type A EBV without the 30-bp LMP1 gene deletion. The overall survival was significantly associated with serum LDH level, Eastern Cooperative Oncology Group (ECOG) performance status, International Prognostic Index (IPI) score, and therapy (p < 0.05), but not associated with any mutation, EBV strain or deletion in EBV LMP1 gene. In conclusion, mutational analysis of ENKTL from Latin America reveals frequent gene mutations leading to activation of the JAK-STAT pathway (25%), mostly STAT3. Compared to Asian cohorts, BCOR, DDX3X  and TP53 mutations were also identified but with different frequencies. None of these mutations were associated with prognosis.

Entities:  

Mesh:

Year:  2019        PMID: 31822801     DOI: 10.1038/s41379-019-0415-5

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  47 in total

1.  Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma.

Authors:  Masayoshi Nagamine; Miki Takahara; Kan Kishibe; Toshihiro Nagato; Hideyuki Ishii; Nobuyuki Bandoh; Takeshi Ogino; Yasuaki Harabuchi
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

2.  Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study.

Authors:  Tawatchai Pongpruttipan; Sanya Sukpanichnant; Thamathorn Assanasen; Pongsak Wannakrairot; Paisarn Boonsakan; Wasana Kanoksil; Kanita Kayasut; Winyou Mitarnun; Archrob Khuhapinant; Udomsak Bunworasate; Teeraya Puavilai; Anan Bedavanija; Adriana Garcia-Herrera; Elias Campo; James R Cook; John Choi; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

3.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.

Authors:  E S Jaffe; N L Harris; J Diebold; H K Muller-Hermelink
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

4.  Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.

Authors:  Gabriela Gualco; Pollyanna Domeny-Duarte; Lucimara Chioato; Glen Barber; Yasodha Natkunam; Carlos E Bacchi
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

5.  High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.

Authors:  S Dirnhofer; A Angeles-Angeles; C Ortiz-Hidalgo; E Reyes; E Gredler; J Krugmann; F Fend; L Quintanilla-Martinez
Journal:  Hum Pathol       Date:  1999-07       Impact factor: 3.466

Review 6.  Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.

Authors:  P Kanavaros; J Briere; J F Emile; P Gaulard
Journal:  Leukemia       Date:  1996-06       Impact factor: 11.528

7.  Expression of natural killer cell markers in non-Hodgkin's lymphomas.

Authors:  C S Ng; J K Chan; S T Lo
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

Review 8.  Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature.

Authors:  Cafer Adiguzel; Suheyla Uyar Bozkurt; Isik Kaygusuz; Ant Uzay; Tulay Tecimer; Mahmut Bayik
Journal:  APMIS       Date:  2009-03       Impact factor: 3.205

9.  An A91V SNP in the perforin gene is frequently found in NK/T-cell lymphomas.

Authors:  Rebeca Manso; Socorro María Rodríguez-Pinilla; Luis Lombardia; Gorka Ruiz de Garibay; Maria Del Mar López; Luis Requena; Lydia Sánchez; Margarita Sánchez-Beato; Miguel Ángel Piris
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

Review 10.  Nasal NK/T-Cell Lymphoma. A Comparative Analysis of a Mexican Population with the Other Populations of Latin-America.

Authors:  Agustin Avilés
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-09-01       Impact factor: 2.576

View more
  10 in total

1.  Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.

Authors:  Elina Parri; Heikki Kuusanmäki; Daria Bulanova; Satu Mustjoki; Krister Wennerberg
Journal:  Blood Adv       Date:  2021-04-13

Review 2.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

Review 3.  New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Authors:  Leticia Quintanilla-Martinez; Steven H Swerdlow; Thomas Tousseyn; Carlos Barrionuevo; Shigeo Nakamura; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-11       Impact factor: 4.535

4.  Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma.

Authors:  Gehong Dong; Xuxiang Liu; Lifu Wang; Wenjuan Yin; Alyssa Bouska; Qiang Gong; Kunal Shetty; Lu Chen; Sunandini Sharma; Jibin Zhang; Carmen Lome-Maldonado; Leticia Quintanilla-Martinez; Yuping Li; Joo Y Song; Wenyan Zhang; Yunfei Shi; Jinhui Wang; Lingbo Kong; Xiwei Wu; Jingwen Wang; Hong-Gang Liu; Lingfei Kong; Wenyong Sun; Weiping Liu; Lili Wang; Timothy W McKeithan; Javeed Iqbal; Wing C Chan
Journal:  Leukemia       Date:  2022-06-13       Impact factor: 12.883

Review 5.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

Review 6.  Estimating the global burden of Epstein-Barr virus-related cancers.

Authors:  Yide Wong; Michael T Meehan; Scott R Burrows; Denise L Doolan; John J Miles
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-27       Impact factor: 4.553

Review 7.  Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine.

Authors:  Ka-Hei Murphy Sun; Yin-Ting Heylie Wong; Ka-Man Carmen Cheung; Carmen Michelle Yuen; Yun-Tat Ted Chan; Wing-Yan Jennifer Lai; Chun David Chao; Wing-Sum Katie Fan; Yuen-Kiu Karen Chow; Man-Fai Law; Ho-Chi Tommy Tam
Journal:  Diagnostics (Basel)       Date:  2022-02-05

Review 8.  EBV and the Pathogenesis of NK/T Cell Lymphoma.

Authors:  Ivonne A Montes-Mojarro; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

Review 9.  NK-/T-cell lymphomas.

Authors:  Hua Wang; Bi-Bo Fu; Robert Peter Gale; Yang Liang
Journal:  Leukemia       Date:  2021-06-11       Impact factor: 11.528

10.  The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.

Authors:  Yang Wang; Huaicheng Tan; Ting Yu; Xuelei Ma; Xiaoxuan Chen; Fangqi Jing; Liqun Zou; Huashan Shi
Journal:  BMC Cancer       Date:  2021-12-06       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.